All In Biotech

Drug Trial Radar · NCT06449859

A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects

A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TQC2938 Injection in Healthy Adult Subjects After Single and Multiple Administration

Last checked: Nov 19, 2026Latest source record: Jun 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

84

Planned (sponsor's estimate)

Start

Jun 13, 2023

Primary completion

Nov 2024

Study completion Nov 2024

Sponsor

Sponsor type
Industry
First posted
Jun 10, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study is designed in two phases: single-dose administration and multiple-dose administration. A randomized, double-blind, placebo-controlled trial design was used to evaluate the safety, tolerability, pharmacokinetic characteristics and immunogenicity of TQC2938 injection in healthy adults.

Conditions

  • Asthma

Interventions

  • TQC2938 InjectionDrug

    TQC2938 injection is a humanized monoclonal antibody that interfering with the signal cascade.

  • TQC2938 PlaceboDrug

    TQC2938 Placebo is a placebo comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse events (AEs)Time frame: Single dose: Up to Day 113. Multiple doses: Up to Day 169
  2. Serious adverse events (SAEs)Time frame: Single dose: Up to Day 113. Multiple doses: Up to Day 169
  3. Clinical laboratory abnormalitiesTime frame: Single dose: Up to Day 113. Multiple doses: Up to Day 169

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.